

















































Expression of UCPs in Obese and Insulin Resistant Mice Induced by Gold Thioglucose
Keiji Imamaki (Fourth Department of Internal Medicine, Saitama Medical School, Moroyama, Iruma-gun, Saitama 
350-0495, Japan)
Both uncoupling proteins, UCP2 and UCP3, show high homologies to UCP1, a mitochondrial carrier protein, 
which has been shown to play a role in the regulation of energy metabolism. UCP3 gene is expressed abundantly in 
the skeletal muscles while UCP2 gene is expressed in the white adipose cells in various tissues of the body. Based on 
their homologies to UCP1, UCP2 and UCP3 are believed to be involved in the regulation of energy balance. In this 
paper, we examined whether the expression of UCP2 and UCP3 is affected in obese and hyperglycemic mice, since 
obesity is associated with disturbed energy and glucose metabolism. We generated obese and hyperglycemic mice 
by using gold thioglucose (GTG) at the age of 6 weeks. Body weight were significantly increased at the age of 11, 16 
and 26 weeks in GTG mice in comparison with control mice. Plasma glucose and insulin levels of GTG mice at the 
age of 11 weeks increased more than those of control mice. Pancreatic beta cell mass also increased significantly in 
GTG mice at the age of 16 weeks. We found that UCP2 mRNA levels in skeletal muscle of GTG mice were higher 
than those of control mice by 5.2-fold (16 weeks) and 2.9-fold (26 weeks), respectively. We also found that UCP3 
mRNA levels in the skeltal muscle of GTG mice were higher than those of control mice by 2.7-fold (16 weeks) and 
2.3-fold (26 weeks), respecively. Thus, the present study supports the concept that UCP2 and UCP3 may profoundly 
contribute to improvement of obesity and glucose metabolism in GTG induced obese mice via thrifty effects on heat 
production.
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に用いた．マウスは室温 221 Cﾟ，湿度 555％，明
暗周期 12時間（点灯７時，消灯 19時）の環境下で飼
育した．固形飼料は，オリエンタル酵母工業株式会社
製の飼料（359 kcal/100 g中水分 7％，粗蛋白質 24.5％，
粗脂肪 4.9％，粗灰分 6.6％，粗繊維 2.7％，可溶性無
窒素物 54.3％，ビタミンA 1300 IU，ビタミンE 6.7 mg，
ビタミンB1 2.0 mg，ビタミンB2 1.1 mg，ビタミンB6 
1.2 mg，ビタミンB12 5.9 g，カルシウム 1.01 g，リ









cholesterol （TC），Triglyceride （TG），Free fatty acid 
（FFA），レプチン値を測定した．なお，血糖は簡易血
糖測定器を用いて測定した．TCはHDAOS法（WAKO 
Japan Co. Ltd., Osaka, Japan），TGはGPO，HDAOS法
（WAKO Japan Co. Ltd., Osaka, Japan），FFAはNEFA-SS






















抗体で反応後，LSAB Kit （DAKO Japan Co. Ltd., Kyoto, 




（1:200希釈）で反応後，Vectastain ABC-AP Kit （Vector 
Co, Ltd., USA）, Alkaline Phosphatase Substrate Kit III 
（Vector Co. Ltd., CA, USA）を用いて青色に染色した．
膵 細胞量の評価はBouwenらの方法5）に従った．す
なわち，各組織標本上の膵組織全体像と全膵島像を
CCDカメラ（Olympus Co. Ltd., Tokyo, Japan）を介し
て 顕 微 鏡（Olympus Co. Ltd., Tokyo, Japan）に て
Macintosh コンピュータ（Apple Co. Ltd., CA, USA）に







析した．Micro Macs mRNA isolation kit（第一化学薬
品株式会社）を用いて，各週齢の骨格筋より抽出した
mRNA （200 ng）にantisense primerと逆転酵素を用いて
一本鎖cDNAを合成し，これをPCR反応の基質とした．
PCR反応は，sense primerとantisense primerおよびTaq 
polymeraseを用いて 40サイクル施行した．反応条件
はdenature （94 Cﾟ 30 秒 ），annealing （60 Cﾟ 1 分 ），










定量分析にはUltra violet products （UVP）社のImage 













gに対しGTG群 25.40.894 g ，16 週ではcontrol群
25.90.97 gに対して 38.36.094 g，26週ではcontrol





群は前値で 0.2110.94 U/ml，60分値 0.4600.195 
U/ml，120分値 0.7920.391 U/mlであったのに対
し，GTG群では前値で 0.5560.160 U/ml，60分値




は前値で 0.2340.206 U/ml ，60 分値 0.8830.539 
U/ml，120分値 0.6170.401 U/mlであったのに対
し，GTG群では前値で 0.8400.226 U/ml，60分値








で 0.850.173 ng/ml，GTG群で 15.8673.715 ng/ml，
16週ではcontrol群で 0.7750.250 ng/ml，GTG群で
16.8712.430 ng/ml ，26 週 で はcontrol群 で





し 16週で 0.5820.181 vs 1.2600.459と明らかな増加





Fig. 1. Comparison of body weight in the control and GTG-
treated groups at the age of 11, 16 and 26 weeks. Body weight 
were significantly increased at the age of 11, 16 and 26 weeks 
in GTG mice in comparison with age matched control mice. 
＃0.05. Also body weight were significantly increased at the 
age of 11, 16 and 26 weeks in GTG mice in comparison with 
at the age of 6 weeks in control mice. ＊0.05 (meanSD), C: 
control, GTG: Gold thioglucose.
Fig. 2. Responses of plasma glucose (PG) and IRI levels 
to IPGTT in control and GTG-treated  groups at the age of 
11 and 26 weeks. Plasma glucose and insulin levels were 
significantly increased at the age of 11 weeks in GTG mice in 
comparison with control mice. ＊0.05  (meanSE),  ■: GTG, 
◆ : control.
Total cholesterol (TC), Triglyceride (TG), Free fatty acid 
(FFA) levels of GTG mice at the age of 11, 16 and 26 
weeks increased significantly more than those of control mice. 
＊0.001  (meanSD), C: control, GTG: Gold thioglucose.
Table 1. Profiles of lipid metabolism of control and GTG group
167
今牧　啓二
週で 0.3720.158 vs 0.3660.248 control群に比しGTG
群の 16週で 0.2180.095 vs 1.1370.277 control群に






週で 0.4150.031 vs 0.5000.163，control群に比しGTG
群の 16 週で 0.8110.124 vs 2.2090.753 ，control群







































Fig. 3. Serum leptin levels in control and GTG-treated 
groups at the age of 11, 16 and 26 weeks. Serum leptin levels 
were significantly increased at the age of 11, 16 and 26 
weeks in GTG mice in comparison with age matched control 
mice. ＃0.05. Also Serum leptin levels were significantly 
increased at the age of 11, 16 and 26 weeks in GTG mice in 
comparison with at the age of 6 weeks in control mice. ＊
0.05 (meanSD), C: control, GTG: Gold thioglucose.
Fig. 5(A), (B). Quantitation of UCP2 (A) and UCP3 (B) gene 
expression in skeletal muscle was performed during the 
disease development. Densitometric analyses were perfomed 
to quantitate relative ratios between UCPs gene and -actin 
gene in 11, 16 and 26 weeks . ＃0.001. Also UCP2 (A) and 
UCP3 (B) gene expression were significantly increased at the 
age of 11, 16 and 26 weeks in GTG mice in comparison with 
at the age of 6 weeks in control mice. ＊0.05 (meanSD), 
＊0.001 (meanSD), C: control, GTG: Gold thioglucose.
Fig. 4. Pancreatic beta-cell mass in control and GTG-
treated groups at the age of 11, 16 and 26 weeks. Pancreatic 
beta cell mass was significantly increased in GTG mice at 
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